Please login to the form below

Not currently logged in
Email:
Password:

Celgene appoints UK inflammation and immunology director

Rob Moore joins from Abbott
celgene Rob-Moore

Celgene has appointed Rob Moore to head its inflammation and immunology business in the UK and Ireland.

Moore joins from AbbVie (formerly Abbott) where he was rhemautology senior business unit manager for the UK.

During his time at Abbott/AbbVie Moore worked across Western Europe and Canada, including two years in Paris as immunology commercial director, dermatology.

He also set up and led the UK sales team in gastroenterology before moving on to create the business unit for dermatology in 2009, wherein he led the launch of the huge-selling anti-inflammatory drug Humira (adalimumab).

Sam Pearce, VP and general manager, Celgene UK and Ireland, said: “We have an opportunity here to offer effective solutions to patients in need, and are confident that Rob has the knowledge and experience to help us deliver these. “

14th March 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...
white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics